LONG NAGOMI™ PMCF STUDY

NCT07399002 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1039

Last updated 2026-04-13

No results posted yet for this study

Summary

The study is designed as a prospective, multi-center, observational PMCF (post-market clinical follow-up) study of the Ultimaster Nagomi™ \_stent (lengths of 38, 44 and 50 mm) in the treatment of coronary artery disease according to the indications approved in the CE marking.

Conditions

Interventions

DEVICE

LONG NAGOMI

Patients in whom treatment with long nagomi has been attempted

Sponsors & Collaborators

  • Fundación EPIC

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-27
Primary Completion
2028-01-01
Completion
2029-01-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07399002 on ClinicalTrials.gov